Nicotinamide

尼克酰胺

Report date: 2026/05/23 20:00:57
NME

Base Information

Drug NameNicotinamide
Drug Alias NameNicotinamidum维生素B3烟酰胺Vitamin B3Papulex
ClassificationSmall molecules > Amino acid supplement, Lipids and Vitamins
Mechanisms of ActionMitogen-activated protein kinase inhibitors
TargetsMitogen-activated protein kinase
Therapy Area/IndicationsParturitionCognitive DysfunctionPostoperative Complications +[37] 
Global Approved IndicationsPellagraVitamin B DeficiencyArrhythmias, Cardiac
Approved Indications in ChinaPellagraVitamin B DeficiencyArrhythmias, Cardiac
Original Approved Country/TerritoryJapan
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesNetherlands +[16] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesUtah State UniversityCanadian Institutes Of Health Research (Cihr)Institut National De La Santé Et De La Recherche Médicale, France U979 +[18] 
Inactive CompaniesRadboud University Medical CenterWashington University School Of MedicineMedice Arzneimittel Pütter Gmbh & Co Kg +[6] 
Active IndicationsParturitionCognitive DysfunctionPostoperative Complications +[28] 
Inactive IndicationsHyperphosphatemiaHypertensionHypertension, Pregnancy-Induced +[9] 

Other Information

ATC CodeA11HA01
Related LinksWikipediaDrugBankKEGG